Role of cholestyramine in refractory hyperthyroidism: A case report and literature review

American Journal of Case Reports

Volumn 16, Issue , 2015, Pages 486-490

  Alswat, Khaled A ^a  

^a TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

Cholestyramine resin; Hyperthyroidism; Iodine

Indexed keywords

ALFACALCIDOL; CALCIUM CARBONATE; CARBIMAZOLE; COLESTYRAMINE; DEXAMETHASONE; HYDROCORTISONE; IODINE; LEVOTHYROXINE; LIOTHYRONINE; PROPRANOLOL; THYROTROPIN; THYROXINE; ANION EXCHANGE RESIN;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSPNEA; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GOITER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; HYPOCALCEMIA; MORNING DOSAGE; NECK MALFORMATION; PARESTHESIA; SNORING; SWELLING; SYMPTOM; THYROID FUNCTION TEST; THYROID NODULE; THYROIDECTOMY; TREATMENT DURATION; TREATMENT RESPONSE; MIDDLE AGED;

ANION EXCHANGE RESINS; CHOLESTYRAMINE RESIN; FEMALE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED;

EID: 84938804037     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.893821     Document Type: Article

References (11)

1. Spitzweg C, Morris JC: Sodium iodide symporter (NIS) and thyroid. Hormons, 2002; 1(1): 22-34
2. Lawrence JE, Lamm SH, Braverman LE: The use of perchlorate for the prevention of thyrotoxicosis in patients given iodine rich contrast agents. J Endocrinol Invest, 1999; 22(5): 405-7
3. Gardner DF, Centor RM, Utiger RD: Effects of low dose iodide supplementation on thyroid function in normal men. Clin Endocrinol, 1988; 28: 283-88
4. Azizi F, Hedayati M, Rahmani M et al: Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest, 2005; 28(1): 23-29
5. Burman KD, Wartofsky L: Iodine effects on the thyroid gland: biochemical and clinical aspects. Rev Endocr Metab Disord. 2000; 1(1-2): 19-25
6. Saleem T, Sheikh A, Masood Q: Resistant thyrotoxicosis in a patient with graves disease: a case report. J Thyroid Res, 2011; 2011: 649084
7. Tsai WC, Pei D, Wang TF et al: The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf), 2005; 62(5): 521-24
8. Mercado M, Mendoza-Zubieta V, Bautista-Osorio R, Espinoza-de los Monteros AL: Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J Clin Endocrinol Metab, 1996; 81(9): 3191-93
9. Junik R, Sowiński J, Zamysłowska H, Gembicki M: Effect of intravenous methimazole on serum levels of thyroid hormones in patients with hyperthyroidism resistant to oral thyrostatic drugs. Endokrynol Pol, 1989; 40(6): 307-13
10. Bartalena L, Brogioni S, Grasso L et al: Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab, 1996; 81: 2930-33
11. Sebastián-Ochoa A, Quesada-Charneco M, Fernández-García D et al: Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy. Thyroid, 2008; 18(10): 1115-17